{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:27:16Z","timestamp":1772501236897,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12325-025-03455-6","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:00:34Z","timestamp":1766563234000},"page":"791-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PaCE CKD: A Multinational Survey of Health-Related Quality of Life in Patients with Chronic Kidney Disease and Caregivers"],"prefix":"10.1007","volume":"43","author":[{"given":"Ricardo","family":"Correa-Rotter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Chadban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-7769","authenticated-orcid":false,"given":"Juan Jose","family":"Garcia Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Pentakota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thames","family":"Kularatne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Fifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham M.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"1","key":"3455_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12955-020-01559-x","volume":"18","author":"JT Cooper","year":"2020","unstructured":"Cooper JT, Lloyd A, Sanchez JJG, S\u00f6rstadius E, Briggs A, McFarlane P. Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review. Health Qual Life Outcomes. 2020;18(1):310.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"3455_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003954","volume":"19","author":"BR Fletcher","year":"2022","unstructured":"Fletcher BR, Damery S, Aiyegbusi OL, et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLOS Med. 2022;19(4):e1003954.","journal-title":"PLOS Med"},{"issue":"12","key":"3455_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003470","volume":"17","author":"SJ Schrauben","year":"2020","unstructured":"Schrauben SJ, Chen HY, Lin E, et al. Hospitalizations among adults with chronic kidney disease in the United States: a cohort study. PLoS Med. 2020;17(12):e1003470.","journal-title":"PLoS Med"},{"issue":"8","key":"3455_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s11255-023-03516-1","volume":"55","author":"G Hawthorne","year":"2023","unstructured":"Hawthorne G, Lightfoot CJ, Smith AC, Khunti K, Wilkinson TJ. Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study. Int Urol Nephrol. 2023;55(8):2047\u201357.","journal-title":"Int Urol Nephrol"},{"issue":"704","key":"3455_CR5","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.3399\/bjgp20X714125","volume":"71","author":"C MacRae","year":"2021","unstructured":"MacRae C, Mercer SW, Guthrie B, Henderson D. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. Br J Gen Pract. 2021;71(704):e243\u20139.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"3455_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ki.2015.228","volume":"88","author":"M Tonelli","year":"2015","unstructured":"Tonelli M, Wiebe N, Guthrie B, et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015;88(4):859\u201366.","journal-title":"Kidney Int"},{"issue":"11","key":"3455_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165675","volume":"11","author":"MD Jesky","year":"2016","unstructured":"Jesky MD, Dutton M, Dasgupta I, et al. Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study. PLoS ONE. 2016;11(11):e0165675.","journal-title":"PLoS ONE"},{"issue":"2","key":"3455_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1073-4449(98)70003-2","volume":"5","author":"AR Campbell","year":"1998","unstructured":"Campbell AR. Family caregivers: caring for aging end-stage renal disease partners. Adv Ren Replace Ther. 1998;5(2):98\u2013108.","journal-title":"Adv Ren Replace Ther"},{"issue":"3","key":"3455_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jorc.12280","volume":"45","author":"VL Hoang","year":"2019","unstructured":"Hoang VL, Green T, Bonner A. Informal caregivers of people undergoing haemodialysis: associations between activities and burden. J Ren Care. 2019;45(3):151\u20138.","journal-title":"J Ren Care"},{"issue":"9","key":"3455_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/healthcare9091212","volume":"9","author":"B Alshammari","year":"2021","unstructured":"Alshammari B, Noble H, McAneney H, Alshammari F, O\u2019Halloran P. Factors associated with burden in caregivers of patients with end-stage kidney disease (a systematic review). Healthcare. 2021;9(9):1212.","journal-title":"Healthcare"},{"issue":"3","key":"3455_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1053\/j.ajkd.2018.09.006","volume":"73","author":"EL Gilbertson","year":"2019","unstructured":"Gilbertson EL, Krishnasamy R, Foote C, Kennard AL, Jardine MJ, Gray NA. Burden of care and quality of life among caregivers for adults receiving maintenance dialysis: a systematic review. Am J Kidney Dis. 2019;73(3):332\u201343.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"3455_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129015","volume":"10","author":"N Ibrahim","year":"2015","unstructured":"Ibrahim N, Teo SS, Che Din N, Abdul Gafor AH, Ismail R. The role of personality and social support in health-related quality of life in chronic kidney disease patients. PLoS ONE. 2015;10(7):e0129015.","journal-title":"PLoS ONE"},{"issue":"11","key":"3455_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae300","volume":"17","author":"E Driehuis","year":"2024","unstructured":"Driehuis E, Janse RJ, Roeterdink AJ, et al. Informal caregiver burden in dialysis care and how it relates to patients\u2019 health-related quality of life and symptoms. Clin Kidney J. 2024;17(11):sfae300.","journal-title":"Clin Kidney J"},{"issue":"1","key":"3455_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12882-020-01830-9","volume":"21","author":"KK Shah","year":"2020","unstructured":"Shah KK, Murtagh FEM, McGeechan K, Crail SM, Burns A, Morton RL. Quality of life among caregivers of people with end-stage kidney disease managed with dialysis or comprehensive conservative care. BMC Nephrol. 2020;21(1):160.","journal-title":"BMC Nephrol"},{"key":"3455_CR15","doi-asserted-by":"publisher","first-page":"205435812210890","DOI":"10.1177\/20543581221089080","volume":"9","author":"A Walavalkar","year":"2022","unstructured":"Walavalkar A, Craswell A, Gray NA. Experiences of caregivers of patients with conservatively managed kidney failure: a mixed methods systematic review. Can J Kidney Health Dis. 2022;9:20543581221089080.","journal-title":"Can J Kidney Health Dis"},{"key":"3455_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fphar.2018.00770","volume":"9","author":"H Nagasawa","year":"2018","unstructured":"Nagasawa H, Sugita I, Tachi T, et al. The relationship between dialysis patients\u2019 quality of life and caregivers\u2019 quality of life. Front Pharmacol. 2018;9:770.","journal-title":"Front Pharmacol"},{"key":"3455_CR17","unstructured":"EuroQol.org. EQ-5D-5L Valuation. 2023. Available from: https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/valuation-standard-value-sets\/new-uk-eq-5d-5l-valuation-study_blog\/ [accessed 14\/07\/2023]."},{"issue":"4","key":"3455_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40273-021-01100-y","volume":"40","author":"S Al Shabasy","year":"2022","unstructured":"Al Shabasy S, Abbassi M, Finch A, Roudijk B, Baines D, Farid S. The EQ-5D-5L valuation study in Egypt. Pharmacoeconomics. 2022;40(4):433\u201347.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"3455_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7\u201322.","journal-title":"Health Econ"},{"key":"3455_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114519","volume":"292","author":"AP Finch","year":"2022","unstructured":"Finch AP, Meregaglia M, Ciani O, Roudijk B, Jommi C. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Soc Sci Med. 2022;292:114519.","journal-title":"Soc Sci Med"},{"issue":"6","key":"3455_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40258-021-00658-0","volume":"19","author":"C Gutierrez-Delgado","year":"2021","unstructured":"Gutierrez-Delgado C, Galindo-Su\u00e1rez RM, Cruz-Santiago C, et al. EQ-5D-5L health-state values for the Mexican population. Appl Health Econ Health Policy. 2021;19(6):905\u201314.","journal-title":"Appl Health Econ Health Policy"},{"issue":"12","key":"3455_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209344","volume":"13","author":"H-W Lin","year":"2018","unstructured":"Lin H-W, Li C-I, Lin F-J, et al. Valuation of the EQ-5D-5L in Taiwan. PLoS ONE. 2018;13(12):e0209344.","journal-title":"PLoS ONE"},{"issue":"6","key":"3455_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","volume":"36","author":"K Ludwig","year":"2018","unstructured":"Ludwig K, von der Graf Schulenburg JM, Greiner W. German value set for the EQ-5D-5L. Pharmacoeconomics. 2018;36(6):663\u201374.","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"3455_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","volume":"22","author":"AS Pickard","year":"2019","unstructured":"Pickard AS, Law EH, Jiang R, et al. United States valuation of EQ-5D-5L health states using an international protocol. Value Health. 2019;22(8):931\u201341.","journal-title":"Value Health"},{"issue":"6","key":"3455_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11136-005-5994-6","volume":"15","author":"WBF Brouwer","year":"2006","unstructured":"Brouwer WBF, van Exel NJA, van Gorp B, Redekop WK. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006;15(6):1005\u201321.","journal-title":"Qual Life Res"},{"issue":"2","key":"3455_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11136-020-02657-5","volume":"30","author":"DC Voormolen","year":"2021","unstructured":"Voormolen DC, van Exel J, Brouwer W, et al. A validation study of the CarerQol instrument in informal caregivers of people with dementia from eight European countries. Qual Life Res. 2021;30(2):577\u201388.","journal-title":"Qual Life Res"},{"issue":"7","key":"3455_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765.","journal-title":"PLoS ONE"},{"issue":"9","key":"3455_CR28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10198-021-01326-9","volume":"22","author":"MF Janssen","year":"2021","unstructured":"Janssen MF, Pickard AS, Shaw JW. General population normative data for the EQ-5D-3L in the five largest European economies. Eur J Health Econ. 2021;22(9):1467\u201375.","journal-title":"Eur J Health Econ"},{"issue":"2","key":"3455_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10198-018-0955-5","volume":"20","author":"MF Janssen","year":"2019","unstructured":"Janssen MF, Szende A, Cabases J, Ramos-Go\u00f1i JM, Vilagut G, K\u00f6nig HH. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20(2):205\u201316.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"3455_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00713-7","volume":"20","author":"LR Grazziotin","year":"2022","unstructured":"Grazziotin LR, Currie G, Twilt M, et al. Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2022;20(1):51.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"3455_CR31","doi-asserted-by":"publisher","DOI":"10.2196\/12381","volume":"8","author":"OD Mowforth","year":"2019","unstructured":"Mowforth OD, Davies BM, Kotter MR. Quality of life among informal caregivers of patients with degenerative cervical myelopathy: cross-sectional questionnaire study. Interact J Med Res. 2019;8(4):e12381.","journal-title":"Interact J Med Res"},{"issue":"1","key":"3455_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s41687-024-00784-y","volume":"8","author":"M Besser","year":"2024","unstructured":"Besser M, O\u2019Sullivan SB, Bourke S, Longworth L, Barcelos GT, Oluboyede Y. Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study. J Patient Rep Outcomes. 2024;8(1):110.","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"3455_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12955-022-01930-0","volume":"20","author":"ME Clarijs","year":"2022","unstructured":"Clarijs ME, Oemrawsingh A, Br\u00f6ker MEE, Verhoef C, Lingsma H, Koppert LB. Quality of life of caregivers of breast cancer patients: a cross-sectional evaluation. Health Qual Life Outcomes. 2022;20(1):29.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"3455_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12882-018-1120-1","volume":"19","author":"H Jafari","year":"2018","unstructured":"Jafari H, Ebrahimi A, Aghaei A, Khatony A. The relationship between care burden and quality of life in caregivers of hemodialysis patients. BMC Nephrol. 2018;19(1):321.","journal-title":"BMC Nephrol"},{"issue":"4","key":"3455_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.24171\/j.phrp.2020.11.4.08","volume":"11","author":"J Cha","year":"2020","unstructured":"Cha J, Han D. Health-related quality of life based on comorbidities among patients with end-stage renal disease. Osong Public Health Res Perspect. 2020;11(4):194\u2013200.","journal-title":"Osong Public Health Res Perspect"},{"issue":"6","key":"3455_CR36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s10157-025-02628-5","volume":"29","author":"H Nakamura","year":"2025","unstructured":"Nakamura H, Okubo R, Kumagai M, et al. Exploring factors associated with kidney disease quality of life in patients with advanced chronic kidney disease: the reach-J CKD cohort study. Clin Exp Nephrol. 2025;29(6):756\u201376.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"3455_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/j.ajkd.2021.02.327","volume":"78","author":"EA Brown","year":"2021","unstructured":"Brown EA, Zhao J, McCullough K, et al. Burden of kidney disease, health-related quality of life, and employment among patients receiving peritoneal dialysis and in-center hemodialysis: findings from the DOPPS program. Am J Kidney Dis. 2021;78(4):489-500.e1.","journal-title":"Am J Kidney Dis"},{"key":"3455_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182413022","author":"C Lerma","year":"2021","unstructured":"Lerma C, Lima-Zapata LI, Amaya-Aguilar JA, et al. Gender-specific differences in self-care, treatment-related symptoms, and quality of life in hemodialysis patients. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph182413022.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"3455_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12955-024-02317-z","volume":"22","author":"E Zimbudzi","year":"2024","unstructured":"Zimbudzi E, Blessan A, Fraginal D, Gute L, Wang Q, Ziganay S. Predictors of quality of life among caregivers of patients with moderate to severe kidney disease: an Australian cross-sectional study. Health Qual Life Outcomes. 2024;22(1):106.","journal-title":"Health Qual Life Outcomes"},{"key":"3455_CR40","unstructured":"World Health Organization. Caregiving impacts on unpaid informal carers\u2019 health and well-being - a gender perspective: factsheet. 2022. Available at: https:\/\/www.who.int\/europe\/publications\/caregiving-impacts-on-unpaid-informal-carers--health-and-well-being---a-gender-perspective--factsheet [Accessed 10\/11\/2025]."},{"issue":"1","key":"3455_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12955-020-01449-2","volume":"18","author":"A Chuasuwan","year":"2020","unstructured":"Chuasuwan A, Pooripussarakul S, Thakkinstian A, Ingsathit A, Pattanaprateep O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1):191.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"3455_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS, Joshi M, Yan G, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98\u2013107.","journal-title":"Am J Nephrol"},{"key":"3455_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1477-7525-1-72","volume":"1","author":"HM Tseng","year":"2003","unstructured":"Tseng HM, Lu JF, Gandek B. Cultural issues in using the SF-36 health survey in Asia: results from Taiwan. Health Qual Life Outcomes. 2003;1:72.","journal-title":"Health Qual Life Outcomes"},{"issue":"7-8","key":"3455_CR44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1365-2702.2009.02840.x","volume":"19","author":"W-F Ma","year":"2010","unstructured":"Ma W-F, Huang X-Y, Chang H-J, Yen W-J, Lee S. Impact of Taiwanese culture on beliefs about expressing anxiety and engaging in physical activity: a discursive analysis of the literature. J Clin Nurs. 2010;19(7\u20138):969\u201377.","journal-title":"J Clin Nurs"},{"issue":"2","key":"3455_CR45","doi-asserted-by":"publisher","first-page":"NP1880","DOI":"10.1177\/1010539512443975","volume":"27","author":"LC Chu","year":"2015","unstructured":"Chu LC. The effects of cultural values on mental health among the Taiwanese people: mediating of attitudes toward emotional expression. Asia Pac J Public Health. 2015;27(2):NP1880\u201392.","journal-title":"Asia Pac J Public Health"},{"issue":"9631","key":"3455_CR46","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","volume":"371","author":"CP Wen","year":"2008","unstructured":"Wen CP, Cheng TYD, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet. 2008;371(9631):2173\u201382.","journal-title":"Lancet"},{"key":"3455_CR47","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jfma.2021.12.009","volume":"121","author":"S-F Tsai","year":"2022","unstructured":"Tsai S-F, Lin M-H, Hsu C-C, Wu M-J, Wang IK, Chen C-H. Trends of kidney transplantation from the 2020 annual report on kidney disease in Taiwan. J Formos Med Assoc. 2022;121:S20\u20139.","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"3455_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040286","volume":"10","author":"SD Fraser","year":"2020","unstructured":"Fraser SD, Barker J, Roderick PJ, et al. Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study. BMJ Open. 2020;10(8):e040286.","journal-title":"BMJ Open"},{"issue":"1","key":"3455_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12882-023-03355-3","volume":"24","author":"S So","year":"2023","unstructured":"So S, Brown MA, Li K. Factors associated with quality of life in patients with kidney failure managed conservatively and with dialysis: a cross-sectional study. BMC Nephrol. 2023;24(1):322.","journal-title":"BMC Nephrol"},{"issue":"6","key":"3455_CR50","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfaa031","volume":"36","author":"MLR Wyld","year":"2021","unstructured":"Wyld MLR, Morton RL, Aouad L, Magliano D, Polkinghorne KR, Chadban S. The impact of comorbid chronic kidney disease and diabetes on health-related quality-of-life: a\u00a012-year community cohort study. Nephrol Dial Transplant. 2021;36(6):1048\u201356.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"3455_CR51","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2215\/CJN.09990915","volume":"11","author":"AC Porter","year":"2016","unstructured":"Porter AC, Lash JP, Xie D, et al. Predictors and outcomes of health-related quality of life in adults with CKD. Clin J Am Soc Nephrol. 2016;11(7):1154\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3455_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MNH.0000000000000270","volume":"25","author":"SD Fraser","year":"2016","unstructured":"Fraser SD, Taal MW. Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment. Curr Opin Nephrol Hypertens. 2016;25(6):465\u201372.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"3455_CR53","first-page":"88","volume":"7","author":"S Farzi","year":"2019","unstructured":"Farzi S, Farzi S, Moladoost A, Ehsani M, Shahriari M, Moieni M. Caring burden and quality of life of family caregivers in patients undergoing hemodialysis: a descriptive-analytic study. Int J Community Based Nurs Midwifery. 2019;7(2):88\u201396.","journal-title":"Int J Community Based Nurs Midwifery"},{"issue":"4","key":"3455_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100439","volume":"4","author":"SN Michalopoulos","year":"2022","unstructured":"Michalopoulos SN, Gauthier-Loiselle M, Aigbogun MS, et al. Patient and care partner burden in CKD patients with and without anemia: a US-based survey. Kidney Med. 2022;4(4):100439.","journal-title":"Kidney Med"},{"issue":"3","key":"3455_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230512","volume":"15","author":"S Elshahat","year":"2020","unstructured":"Elshahat S, Cockwell P, Maxwell AP, Griffin M, O\u2019Brien T, O\u2019Neill C. The impact of chronic kidney disease on developed countries from a health economics perspective: a systematic scoping review. PLoS ONE. 2020;15(3):e0230512.","journal-title":"PLoS ONE"},{"issue":"3","key":"3455_CR56","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382\u201395.","journal-title":"Lancet Glob Health"},{"key":"3455_CR57","doi-asserted-by":"publisher","DOI":"10.4103\/jehp.jehp_273_24","volume":"13","author":"A Azeez","year":"2024","unstructured":"Azeez A, Ambatipudi S. Caregiver burden and quality of life among family caregivers of hemodialysis patients from South India. J Educ Health Promot. 2024;13:486.","journal-title":"J Educ Health Promot"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03455-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:03:07Z","timestamp":1771268587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03455-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03455-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ricardo Correa Rotter has received honoraria as consultant from AstraZeneca, Boehringer Ingelheim, Bayer, Chinook, AbbVie, Novo Nordisk and Lilly, and research support from AstraZeneca, Boehringer Ingelheim, Roche, Lilly, Chinook and Novo Nordisk. He has received honoraria\/speaking fees from AstraZeneca, Boehringer Ingelheim, Novo Nordisk and Amgen. Mai-Szu Wu has received support from AstraZeneca for their contributions to this work, and payment\/honoraria for lectures, presentations, and manuscript writing. He has received payment\/honoraria from Baxter, Bayer, GSK, Novartis, Pfizer and Sanofi for lectures and presentations and honoraria for advisory board participation from AstraZeneca, Bayer, GSK, Novartis and Sanofi. Richard Hull has received speaking fees from AstraZeneca, Boehringer Ingelheim, Bayer and Thornton Ross Stada Group, and honoraria for advisory board participation from Novartis, Travere Therapeutics and Vifor Fresenius. Ciro Esposito has received payment\/honoraria from AstraZeneca, Otsuka, Travere Therapeutics and Vifor Fresenius for speaker fees and advisory board. Helmut Reichel has no conflicts to disclose. Steven Chadban has received payment\/honoraria from AstraZeneca, Boehringer Ingelheim, and Bayer for speaker fees and advisory boards. Juan Jose Garcia Sanchez and Surendra Pentakota are employees of AstraZeneca. Simon Fifer and Thames Kularatne are employees of CaPPRe PTY Ltd. which received fees from AstraZeneca to conduct this study. CaPPRe has consulted to AbbVie, Amgen, Bristol Myers Squibb, Celgene, CSL Behring, Edwards LifeSciences, Gilead, GSK, Ipsen, Janssen, Medtronic, Novo Nordisk, Roche, Sanofi, Seqirus, Shire, UCB, and Vertex outside of the submitted work. Hesham M. Elsayed has received payment\/honoraria from AstraZeneca, Boehringer Ingelheim, Bayer, and GSK for symposia and is Emeritus Professor of Nephrology, ESNT President Elect, and Academic Director of RRT WKA Fellowship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed by an international Institutional Review Board, Pearl IRB, and was granted an exemption from a full review due to its low\/negligible risk nature in accordance with FDA 21 56.104 and 45CFR46.104. (Protocol #21-CAPP-102). All participants provided electronic informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}